1. Home
  2. STKH vs VRAX Comparison

STKH vs VRAX Comparison

Compare STKH & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steakholder Foods Ltd.

STKH

Steakholder Foods Ltd.

HOLD

Current Price

$2.00

Market Cap

3.4M

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.26

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKH
VRAX
Founded
2018
2013
Country
Israel
United Kingdom
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
2.9M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
STKH
VRAX
Price
$2.00
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
131.2K
260.1K
Earning Date
04-02-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,000.00
$2,986.00
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$0.26
52 Week High
$67.20
$2.29

Technical Indicators

Market Signals
Indicator
STKH
VRAX
Relative Strength Index (RSI) 37.88 31.96
Support Level $2.45 $0.26
Resistance Level $2.75 $0.29
Average True Range (ATR) 0.27 0.02
MACD -0.04 0.00
Stochastic Oscillator 7.84 6.74

Price Performance

Historical Comparison
STKH
VRAX

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: